Rxivist logo

Study protocol for COvid-19 Vascular sERvice (COVER) study: The impact of the COVID-19 pandemic on the provision, practice and outcomes of vascular surgery

By Vascular and Endovascular Research Network, Ruth A Benson, Dave C Bosanquet, Sandip Nandhra, Joseph Shalhoub, Athanasios Saratzis, Rachel Forsythe, Sarah Onida, George Dovell, Louise Hitchman, Nikesh Dattani, Ryan Preece, Graeme K Ambler, Christopher Imray

Posted 29 May 2020
medRxiv DOI: 10.1101/2020.05.27.20114322

Background: The novel Coronavirus Disease 2019 (COVID-19) pandemic is having a profound impact on global healthcare. Shortages in staff, operating theatre space and intensive care beds has led to a significant reduction in the provision of surgical care. Even vascular surgery, often insulated from resource scarcity due to its status as an urgent specialty, has limited capacity due to the pandemic. Furthermore, many vascular surgical patients are elderly with multiple comorbidities putting them at increased risk of COVID-19 and its complications. There is an urgent need to investigate the impact on patients presenting to vascular surgeons during the COVID-19 pandemic. Methods and Analysis: The COvid-19 Vascular sERvice (COVER) study has been designed to investigate the worldwide impact of the COVID-19 pandemic on vascular surgery, at both service provision and individual patient level. COVER is running as a collaborative study through the Vascular and Endovascular Research Network (VERN) with the support of numerous national (Vascular Society of Great Britain and Ireland, British Society of Endovascular Therapy, British Society of Interventional Radiology, Rouleaux Club) and an evolving number of international organisations (Vascupedia, SingVasc, Audible Bleeding (USA), Australian and New Zealand Vascular Trials Network (ANZVTN)). The study has 3 Tiers: Tier 1 is a survey of vascular surgeons to capture longitudinal changes to the provision of vascular services within their hospital; Tier 2 captures data on vascular and endovascular procedures performed during the pandemic; and Tier 3 will capture any deviations to patient management strategies from pre-pandemic best practice. Data submission and collection will be electronic using online survey tools (Tier 1: SurveyMonkey for service provision data) and encrypted data capture forms (Tiers 2 and 3: REDCap for patient level data). Tier 1 data will undergo real-time serial analysis to determine longitudinal changes in practice, with country-specific analyses also performed. The analysis of Tier 2 and Tier 3 data will occur on completion of the study as per the pre-specified statistical analysis plan. Ethical Approval: Ethical approval from the UK Health Research Authority has been obtained for Tiers 2 and 3 (20/NW/0196 Liverpool Central). Participating centres in the UK will be required to seek local research and development approval. Non-UK centres will need to obtain a research ethics committee or institutional review board approvals in accordance with national and/or local requirements. ISRCTN: 80453162 (https://doi.org/10.1186/ISRCTN80453162) Ethical Approval: 20/NW/0196 Liverpool Central, IRAS: 282224

Download data

  • Downloaded 496 times
  • Download rankings, all-time:
    • Site-wide: 58,173
    • In surgery: 22
  • Year to date:
    • Site-wide: 98,565
  • Since beginning of last month:
    • Site-wide: 83,613

Altmetric data


Downloads over time

Distribution of downloads per paper, site-wide


PanLingua

News